Phio Pharmaceuticals Corp. (PHIO) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Phio Pharmaceuticals reported revenue of $0. Net income was -$8.7M. Operating activities generated -$8.0M of cash, leaving -$8.0M of free cash flow. At fiscal year end, Phio Pharmaceuticals held $21.5M in total assets against $1.3M in total liabilities, including $21.0M of cash and equivalents.
Open the full interactive Phio Pharmaceuticals financials → Quarterly statements, key ratios, valuation history and price charts.
Phio Pharmaceuticals Key Stats
| Share Price | $0.94 |
|---|---|
| Market Cap | $10.9M |
| 52-Week Range | $0.86 – $2.24 |
| Shares Outstanding | 11.6 million (basic, 2026 Q2) |
Phio Pharmaceuticals Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$8.8M | -$13.5M | -$11.5M | -$10.8M | -$7.4M | -$9.2M |
| Pre-Tax Income | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | -$8.7M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | -$8.7M |
| Diluted EPS | -$207.36 | -$112.32 | -$90.90 | -$46.80 | -$9.08 | — |
Phio Pharmaceuticals Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$2.4M | -$2.4M | -$4.0M | -$4.1M |
Phio Pharmaceuticals Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | — | — | — | — | $5.4M | $21.0M |
| Current Assets | $15.2M | $24.7M | $12.4M | $9.3M | $5.7M | $21.5M |
| Total Assets | $15.7M | $25.2M | $12.8M | $9.4M | $5.7M | $21.5M |
| Current Liabilities | $2.2M | $3.1M | $1.9M | $1.6M | $1.0M | — |
| Total Long-Term Debt | $231,000 | — | — | — | — | — |
| Total Liabilities | $2.7M | $3.2M | $2.0M | $1.6M | $1.0M | $1.3M |
| Shareholders' Equity | $13.0M | $21.9M | $10.8M | $7.7M | $4.7M | $20.1M |
Phio Pharmaceuticals Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$8.8M | -$11.9M | -$12.1M | -$10.7M | -$7.1M | -$8.0M |
| Cash From Investing | -$19,000 | -$51,000 | -$121,000 | -$5,000 | $8,000 | -$12,000 |
| Cash From Financing | $16.1M | $21.7M | -$26,000 | $7.4M | $4.0M | $23.6M |
| Free Cash Flow | -$8.8M | -$11.9M | -$12.2M | -$10.8M | -$7.1M | -$8.0M |
Figures from Phio Pharmaceuticals' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Phio Pharmaceuticals financials page for every line item.
Phio Pharmaceuticals Company Profile
| Ticker | PHIO |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | King Of Prussia, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001533040 |
Frequently Asked Questions
What was Phio Pharmaceuticals' revenue in fiscal 2025?
Phio Pharmaceuticals (PHIO) reported revenue of $0 for fiscal 2025.
What is Phio Pharmaceuticals' annual revenue history?
Phio Pharmaceuticals' annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Phio Pharmaceuticals' net income in fiscal 2025?
Phio Pharmaceuticals reported net income of -$8.7M for fiscal 2025.
How much free cash flow did Phio Pharmaceuticals generate in fiscal 2025?
Phio Pharmaceuticals generated -$8.0M of free cash flow in fiscal 2025.
What was Phio Pharmaceuticals' revenue last quarter?
In its most recent reported quarter (2026 Q2), Phio Pharmaceuticals reported revenue of $0.
How many shares of Phio Pharmaceuticals are outstanding?
Phio Pharmaceuticals reported a weighted average of 11.6 million basic shares outstanding in 2026 Q2.
What is Phio Pharmaceuticals' market cap?
Based on its latest closing price, Phio Pharmaceuticals (PHIO) has a market capitalization of about $10.9M.
When does Phio Pharmaceuticals' fiscal year end?
Phio Pharmaceuticals' fiscal year end, as registered with the SEC, is December 31.
Where is Phio Pharmaceuticals headquartered?
Phio Pharmaceuticals lists its business address in King Of Prussia, Pennsylvania in its SEC filings.